Public, non-traded

PCAP — Nuveen Churchill Private Capital Income

Nuveen Churchill Private Capital Income is a business development company managed by Churchill Asset Management (Nuveen). Strategy: private debt and equity.

What SpreadVista tracks for PCAP

•Marks-to-par across the entire portfolio. Every position's fair value as a fraction of par cost — the canonical health signal for a private-credit position. We track every PCAP mark quarter-over-quarter, sourced directly from SEC 10-Q/10-K Schedule of Investments tables.
•NAV per share history. PCAP's net asset value per share over time, with the components (interest accrual, gain/loss recognition, distributions) decomposed.
•Non-accrual rate and trend. Which PCAP positions have gone on non-accrual status, the dollar exposure, and the trajectory of credit deterioration.
•Top issuers by fair value. PCAP's concentration profile — the largest 10/25/50 exposures with mark and maturity context.
•Spread surface vs comparable BDCs. Where PCAP's positions sit on the credit-spread surface relative to peer-group BDCs holding similar-rated credits.
•Cross-vehicle issuer exposure. Which other BDCs and interval funds hold the same credits as PCAP— a contagion-risk view incumbents charge $20K–200K per seat for.

See PCAP's full analytics

Free during beta. Every PCAP position, every mark, every non-accrual, every cross-vehicle overlap — sourced directly from SEC filings, with the methodology shown on every chart.

Get Free Access

About PCAP

Ticker: PCAP
Legal name: Nuveen Churchill Private Capital Income
Manager / Advisor: Churchill Asset Management (Nuveen)
Category: Public, non-traded
Strategy: Private debt and equity
Fiscal year end: 12-31
SEC CIK: 1911066 (EDGAR filings) (opens in new tab)

Related concepts

Plain-English explanations of the metrics we track for PCAP:

What SpreadVista tracks for PCAP

•Marks-to-par across the entire portfolio. Every position's fair value as a fraction of par cost — the canonical health signal for a private-credit position. We track every PCAP mark quarter-over-quarter, sourced directly from SEC 10-Q/10-K Schedule of Investments tables.

•NAV per share history. PCAP's net asset value per share over time, with the components (interest accrual, gain/loss recognition, distributions) decomposed.

•Non-accrual rate and trend. Which PCAP positions have gone on non-accrual status, the dollar exposure, and the trajectory of credit deterioration.

•Top issuers by fair value. PCAP's concentration profile — the largest 10/25/50 exposures with mark and maturity context.

•Spread surface vs comparable BDCs. Where PCAP's positions sit on the credit-spread surface relative to peer-group BDCs holding similar-rated credits.

•Cross-vehicle issuer exposure. Which other BDCs and interval funds hold the same credits as PCAP— a contagion-risk view incumbents charge $20K–200K per seat for.